OVERVIEW: Sanofi Genzyme supports medical education programs around the world.
IP TAKE: This approachable funder supports medical education programs at hospitals, research institutions, non-profit organizations and academic institutions.
PROFILE: Genzyme was a biotechnology company that was originally founded in Boston, Massachusetts in 1981. In 2011, Genzyme became a fully owned subsidiary of Sanofi, a French multi-national pharmaceutical company and is now known as Sanofi Genzyme. The company’s philanthropic giving supports a “[d]iverse range of organizations and initiatives,” and a “[d]iversified group of philanthropic causes.” Main areas of grantmaking focus include addressing unmet medical needs, innovative technologies and treatment approaches and improving the lives of patients.
While Sanofi Genzyme does not have a dedicated STEM education program, its giving invests in scientific research that focuses on medical education programs dedicated to expanding medical knowledge and improving global healthcare standards. Sanofi offers grants to accredited and unaccredited medical education programs, as well as, sponsorships, and fellowships.
Sanofi accepts unsolicited grant applications and requests for funding throughout the year. The company asks applicants to submit their materials at least 12 to 16 weeks prior to the request for notification date. The review and processing time takes approximately six to eight weeks. Finally, Sanofi announces Requests for Proposals (RFPs) throughout out the year. RFPs typically focus on research pertaining to a specific disease or therapeutic area.
Search for staff contact info and bios in PeopleFinder (paid subscribers only).